当前位置: X-MOL 学术Mediat. Inflamm. › 论文详情
Our official English website, www.x-mol.net, welcomes your feedback! (Note: you will need to create a separate account there.)
Betulinic Acid Attenuates Osteoarthritis via Limiting NLRP3 Inflammasome Activation to Decrease Interleukin-1β Maturation and Secretion
Mediators of Inflammation ( IF 4.6 ) Pub Date : 2023-9-25 , DOI: 10.1155/2023/3706421
Bo Liu 1, 2, 3 , Yanglin Wu 2, 3, 4 , Ting Liang 3 , Yunlong Zhou 1 , Guangdong Chen 2 , Jiaheng He 2, 3, 5 , Chenchen Ji 2, 3, 6 , Peixin Liu 2, 3, 7 , Chenhui Zhang 2, 3 , Jun Lin 2, 8 , Kece Shi 1 , Zongping Luo 2, 3 , Naicheng Liu 2 , Xinlin Su 2
Affiliation  

Introduction. Osteoarthritis (OA) is the most common degenerative joint disorder. Prior studies revealed that activation of NLRP3 inflammasome could promote the activation and secretion of interleukin-1β (IL-1β), which has an adverse effect on the progression of OA. Betulinic acid (BA) is a compound extract of birch, whether it can protect against OA and the mechanisms involved are still unknown. Materials and Methods. In vivo experiments, using gait analysis, ELISA, micro-CT, and scanning electron microscopy (SEM), histological staining, immunohistological (IHC) and immunofluorescence (IF) staining, and atomic force microscopy (AFM) to assess OA progression after intraperitoneal injection of 5 and 15 mg/kg BA in an OA mouse model. In vitro experiments, caspase-1, IL-1β, and the N-terminal fragment of gasdermin D (GSDMD-NT) were measured in bone marrow-derived macrophages (BMDMs) by using ELISA, western blot, and immunofluorescence staining. Results. We demonstrated that OA progression can be postponed with intraperitoneal injection of 5 and 15 mg/kg BA in an OA mouse model. Specifically, BA postponed DMM-induced cartilage deterioration, alleviated subchondral bone sclerosis, and relieved synovial inflammation. In vitro studies, the activated NLRP3 inflammasome produces mature IL-1β by facilitating the cleavage of pro-IL-1β, and BA could inhibit the activation of NLRP3 inflammasome in BMDMs. Conclusions. Taken together, our analyses revealed that BA attenuates OA via limiting NLRP3 inflammasome activation to decrease the IL-1β maturation and secretion.

中文翻译:

桦木酸通过限制 NLRP3 炎性体激活以减少 IL-1β 成熟和分泌来减轻骨关节炎

介绍。骨关节炎(OA)是最常见的退行性关节疾病。此前的研究表明,NLRP3炎症小体的激活可以促进白细胞介素1β(IL-1β 的激活和分泌,从而对OA的进展产生不利影响。桦木酸(BA)是桦木的复合提取物,其是否具有预防骨关节炎的作用及其机制尚不清楚。材料和方法。体内实验,使用步态分析、ELISA、显微 CT 和扫描电子显微镜 (SEM)、组织学染色、免疫组织学 (IHC) 和免疫荧光 (IF) 染色以及原子力显微镜 (AFM) 评估腹腔注射后 OA 进展在 OA 小鼠模型中,BA 浓度为 5 和 15 mg/kg。体外实验中,使用 ELISA、蛋白质印迹和免疫荧光染色测量骨髓源性巨噬细胞 (BMDM) 中的 caspase-1、IL-1 β 和 Gasdermin D N 末端片段 (GSDMD-NT) 结果。我们证明,在 OA 小鼠模型中腹腔注射 5 和 15 mg/kg BA 可以推迟 OA 进展。具体来说,BA 延缓了 DMM 引起的软骨退化,减轻了软骨下骨硬化,并缓解了滑膜炎症。体外研究发现,激活的NLRP3炎症小体通过促进pro-IL-1β的裂解产生成熟的IL- 并且BA可以抑制BMDMs中NLRP3炎症小体的激活。结论。综上所述,我们的分析表明,BA 通过限制 NLRP3 炎性体激活来减少 IL-1 β 的成熟和分泌,从而减轻 OA。
更新日期:2023-09-25
down
wechat
bug